This study is a prospective, multicenter, observational registry study (based on real-world data). Participants who meet all inclusion and exclusion criteria will be included in this study for the collection of clinical and imaging data, as well as subsequent follow-up. The main objective is to evaluate the incidence and predictive factors of all-cause mortality in CHIP patients one year after PCI surgery. The secondary objectives include evaluating the incidence and predictive factors of major cardiovascular adverse events (MACE) in CHIP patients one year after PCI surgery; Compare the efficacy differences of different revascularization strategies (complete/incomplete revascularization); Analyze the impact of imaging/functional tools (IVUS/OCT/FFT/QFR) on the prognosis of CHIP-PCI; Analyze the impact of MCS on the prognosis of CHIP-PCI; Establish a CHIP patient risk prediction model
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
One year post PCI all-cause mortality
Timeframe: One year after PCI